Dr. Daniel Bettis, M.D.
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 714
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
KS license 04-43912 · MO license 2019017101
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 714
- Services billed
- 2,900
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Removal of cataract with insertion of prosthetic lens | 528 | 297 |
| Measurement of corneal curvature and depth of eye | 509 | 339 |
| New patient office or other outpatient visit, 45-59 minutes | 329 | 329 |
| Exam of visual field with extended testing | 244 | 231 |
| Imaging of optic nerve | 236 | 219 |
| Established patient office or other outpatient visit, 30-39 minutes | 204 | 192 |
| Established patient complete exam of visual system | 143 | 135 |
| Removal of recurring cataract in lens capsule using a laser | 111 | 111 |
| Established patient office or other outpatient visit, 20-29 minutes | 97 | 91 |
| Ultrasound scan of cornea to determine thickness | 62 | 61 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Latanoprost Other prescribers in Kansas City, MO | 637 |
| Prednisolone Acetate Other prescribers in Kansas City, MO | 361 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Kansas City, MO | 321 |
| Tobramycin | 205 |
| Brimonidine Tartrate Other prescribers in Kansas City, MO | 178 |
| Timolol Maleate Other prescribers in Kansas City, MO | 150 |
| Travoprost Other prescribers in Kansas City, MO | 110 |
| Lumigan (bimatoprost) Other prescribers in Kansas City, MO | 61 |
| Dorzolamide Hcl Other prescribers in Kansas City, MO | 44 |
| Combigan (brimonidine tartrate/timolol) Other prescribers in Kansas City, MO | 43 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $500 in research payments for these studies, mostly to the institutions running them.
- Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5%
Glaukos Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.